KRSR selectively enhances the adhesion mechanism of osteoblasts mediated by heparan sulfate. Elucidating such peptide sequences is important for the design of biomaterials in the field of bone cell/tissue engineering and active dental/plastic surgery. Note: The use of this peptide is covered by US Patent 6,262,017 B1 owned by Rensselaer Polytechnic Institute (RPI) in Troy, New York. RPI approved purchasers of 5 grams or less per year to use this peptide for research purposes only. Other purchasers must have written permission from RPI.
K.C.Dee et al., J. Biomed. Mater Res., 40, 371 (1998)